Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
6.99
-0.50 (-6.68%)
At close: Sep 25, 2026, 4:00 PM EDT
7.02
+0.03 (0.43%)
After-hours: Sep 25, 2026, 7:30 PM EDT
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $341.74 million as of September 25, 2026. Its market cap has increased by 385.80% in one year.
Market Cap
341.74M
Enterprise Value
2.20M
1-Year Change
385.80%
Ranking
Category
Stock Price
$6.99
ChartMarket Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has increased from $176.76M to $341.74M, an increase of 93.34%. That is a compound annual growth rate of 35.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 341.74M | 224.55% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 371.89M |
| C4 Therapeutics | 366.61M |
| Orchestra BioMed Holdings | 357.63M |
| Cabaletta Bio | 350.96M |
| Surrozen | 347.20M |
| Enanta Pharmaceuticals | 346.01M |
| Ocugen | 345.89M |
| Vogenx | 337.66M |